Description of Research Expertise:
My research focuses on inflammatory bowel disease specifically Crohn's disease and Ulcerative Colitis. My particular focuses include
1.) medical therapy of inflammatory bowel disease,
2.) safety of current medical therapy for IBD, and
3.) natural history of disease
Selected Publications:
Kotlyar D, Lewis JD, Beaugerie L,Tierney A, Brensinger CM, Gisbert, JP, Loftus E, Peyrin-Biroulet L, Blonski W, Van Domselaar M, Chaparro, M, Sandilya S, Bewtra M, Lichtenstein GR: Risk of Lymphoma among Inflammatory Bowel Disease Patients Treated with Azathioprine and 6-Mercaptopurine: Meta-Analysis of Referral Center Studies and Population-based Studies. Clinical Gastroenterology and Hepatology 13 (5): 847-858,2015.
John Wysocki, Gary R. Lichtenstein, Nabeel Khan: Efficacy of Thiopurines in Achieving Steroid Free Remission in Ulcerative Colitis Patients: A Population Cohort Study Gastroenterology 148 (4 Supplement 1): S 867,2015.
Prashant R. Mudireddy, Frank I. Scott, Alexandra Feathers, Ann Tierney, Gary R. Lichtenstein: Predictors of Early and Late Unplanned Re-Admissions in IBD Patients. Gastroenterology 148 (4 Suppkement 1): S262-S263,2015.
Elisabeth B. Cole, Ali Abbas, Gary R. Lichtenstein, Nabeel Khan.: Temporal Relationship Between Onset of Ulcerative Colitis and Diagnosis of Primary Sclerosing Cholangitis: A Nationwide Population Cohort Study. Gastroenterology 148 (4 Supplement 1): S-479,2015.
Maria Paula Henao, Meenakshi Bewtra, Mark T. Osterman, Faten Aberra, Frank I. Scott, Gary R. Lichtenstein, Jennifer Kraschnewski, James Lewis.: Measurement of Inflammatory Bowel Disease Symptoms: Reliability of an Abbreviated Approach to Data Collection. Gastroenterology 148 (4 Supplement 1): S-443,2015.
Prashant R. Mudireddy, Frank I. Scott, Gary R. Lichtenstein.: Unplanned Hospital Readmission: Rates and Causes in Patients With Inflammatory Bowel Disease: A Critical Analysis Gastroenterology 148 (4 Supplement 1): S-835,2015.
John Wysocki, Gary R. Lichtenstein, Nabeel Khan: Efficacy of Thiopurines in Achieving Mucosal Healing in Ulcerative Colitis Patients: A Population Cohort Analysis Gastroenterology 148 (4 Supplement 1): S-867,2015.
Gary R. Lichtenstein, Edward V. Loftus, Brian G. Feagan, David G. Binion, David Sen, Amanda Golembesky, Gordana Kosutic, Cem Kayhan, Marshall Spearman, Douglas C. Wolf, Scott D. Lee.: Evaluation of Real-World Risk of Malignancies in Crohn's Disease Patients Treated With Certolizumab Pegol: Results From the SECURE Registry. Gastroenterology 148 (4): S-236,2015.
Ravy K. Vajravelu, Mark T. Osterman, Faten Aberra, Gary R. Lichtenstein, James Lewis, Frank I. Scott: Predictors of Indeterminate QuantiFERON-TB Gold Testing in Inflammatory Bowel Disease and Impact on Clinical Outcomes Gastroenterology 148 (4 Supplement 1): S 253,2015.
Gary R. Lichtenstein, Brian G. Feagan, William Sandborn, Iram Hasan, Gordana Kosutic, Jason Coarse, Catherine H. Arendt, Marshall Spearman, Edward V. Loftus.: Serious Infectious Complications in Patients Treated With Certolizumab Pegol: A Pooled Analysis of 15 Crohn's Disease Global Clinical Trials. Gastroenterology 148 (4 Supplement 1): S-236,2015.
View all publications